PER 0.00% 8.1¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-35

  1. 3,122 Posts.
    lightbulb Created with Sketch. 621
    What i would like to know is of the $1M they get, exactly how much of this will be spent on the experiment and how much of it will go towards the Diamonds wage and other under disclosed (cough, cough) "office admin" fees.

    The Diamond needs to chip in here by way of taking a pay cut allowing funds to last longer and more of the money to be spent on what it should be spent on.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
0.000(0.00%)
Mkt cap ! $83.97M
Open High Low Value Volume
8.0¢ 8.1¢ 8.0¢ $61.91K 766.3K

Buyers (Bids)

No. Vol. Price($)
4 549730 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.1¢ 94626 1
View Market Depth
Last trade - 15.59pm 31/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.